Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mahiuddin Ahmed currently holds 150,000 shares of Y-mAbs Therapeutics, Inc. (YMAB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mahiuddin Ahmed has been a net seller of YMAB stock. They have purchased $0 and sold $4.3M worth of shares.
Mahiuddin Ahmed's most recent insider trade was on May 26, 2020, when they sold 50,000 shares at $39.38 per share.
Mahiuddin Ahmed serves as Executive at Y-mAbs Therapeutics, Inc. (YMAB). They have executed 5 insider transactions totaling $4.3M over their tenure at the company.
Mahiuddin Ahmed holds the position of Executive at Y-mAbs Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Mahiuddin Ahmed has shown a selling trading pattern, with $0 in total purchases and $4.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mahiuddin Ahmed was on May 26, 2020, when they sold $2.0M worth of YMAB shares. This transaction involved 50,000 shares at $39.38 per share.
Mahiuddin Ahmed currently owns 150,000 shares of Y-mAbs Therapeutics, Inc. (YMAB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mahiuddin Ahmed's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mahiuddin Ahmed has 5 Form 4 filings on record as an insider at Y-mAbs Therapeutics, Inc..
Set alerts for Mahiuddin Ahmed and 40,000+ other insiders.